| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10962355 | Vaccine | 2016 | 8 Pages |
Abstract
Immunity to meningococcal serogroup C in SCD children declines rapidly after vaccination and is dependent on the age at priming. Booster doses are needed to maintain protection in SCD patients. Persistence of antibodies seems to be longer in individuals primed with MCC-TT vaccine comparing to those immunized with MCC-CRM197.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Alessandra R. Souza, Claudia M. Maruyama, Marco Aurélio P. Sáfadi, Marta H. Lopes, Raymundo S. Azevedo, Helen Findlow, Xilian Bai, Ray Borrow, Lily Y. Weckx,